The Leiden biotech company VarmX will receive 17.5 million euros from an innovation program of the European Union. The money is intended to increase the production of a drug inspired by snake venom. It prevents serious bleeding in patients taking blood thinners, especially during emergency surgery.
–
Related posts:
Israeli Doctors Calling for Bombing Hospitals in Gaza: A Call for Compassion and Humanity
Parliament's health imposes 100 pounds on private school fees for the Emergency Medical Fund
Chandipora... a lethal new virus that would unfold globally Find out about its signs
Let's Control Hypertension to Prevent Covid-19 Severity
